Current Therapeutic Strategies for Anticoagulation in COVID 19 Associated Thromboembolic Disease | Panel Discussion

Thromboembolism resulting from post-Covid-19 infections has resulted in an increased mortality rate. Studies suggest the presence of thrombogenic potential in SARS-CoV-2 originating from inflammatory response leading to a reduction in the anticoagulatory potential of the endothelium. Anticoagulants have been the preferred choice for the treatment of thromboembolism but no standard consensus has be...